(2024)
Tailored radiation dose according to margin width for patients with ductal carcinoma in situ after breast-conserving surgery.
SCIENTIFIC REPORTS.
14,
1
(2023)
The prognostic value of a combined immune score in tumor and immune cells assessed by immunohistochemistry in triple-negative breast cancer.
BREAST CANCER RESEARCH.
25,
1
(2023)
Effect of high-dose radiation therapy on positive margins after breast-conserving surgery for invasive breast cancer.
BREAST.
71,
1
(2023)
Clinical Impact of Genomic and Pathway Alterations in Stage I EGFR-Mutant Lung Adenocarcinoma.
CANCER RESEARCH AND TREATMENT.
56,
1
(2020)
Comprehensive Immuno-Molecular Profiles for Liposarcoma: Roles of Programmed Death Ligand 1, Microsatellite Instability, and PIK3CA.
ONCOLOGY.
98,
11
(2020)
Prognostic significance of glucose-related protein 94 in colorectal cancer.
PATHOLOGY RESEARCH AND PRACTICE.
216,
7
(2020)
Moesin (MSN) as a Novel Proteome-Based Diagnostic Marker for Early Detection of Invasive Bladder Urothelial Carcinoma in Liquid-Based Cytology.
CANCERS.
12,
4
(2020)
Utility of Human Papillomavirus Testing for Cervical Cancer Screening in Korea.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH.
17,
5
(2019)
Differential expression of HSP90 isoforms and their correlations with clinicopathologic factors in patients with colorectal cancer.
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY.
12,
3
(2018)
Genetic and clinicopathologic characteristics of lung adenocarcinoma with tumor spread through air spaces.
LUNG CANCER.
123,
-
(2018)
Expression of miR-200c and its clinicopathological significance in patients with colorectal cancer.
PATHOLOGY RESEARCH AND PRACTICE.
214,
3
(2018)
Droplet digital PCR-based ITEGFR ITmutation detection with an internal quality control index to determine the quality of DNA.
SCIENTIFIC REPORTS.
8,
(2017)
Next-generation sequencing reveals novel resistance mechanisms and molecular heterogeneity in EGFR-mutant non-small cell lung cancer with acquired resistance to EGFR-TKIs.
LUNG CANCER.
113,
-
